1
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, May 31, 2011: US07951789 (28 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


2
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, March 8, 2011: US07902202 (16 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


3
Gilles Gosselin, Jean Louis Imbach, Martin L Bryant: β-L-2′-deoxy-nucleosides for the treatment of hepatitis B. Idenix Pharmaceuticals, Centre National de la Recherche Scientifique, L Université Montpellier II, Jones Day, September 14, 2010: US07795238 (1 worldwide citation)

This invention is directed to a method for treating a host infected with hepatitis B comprising administering an effective amount of an anti-HBV biologically active 2′-deoxy-β-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof, wherein the 2′-deoxy-β-L-erythro-p ...


4

5

6